Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1963 1
1964 3
1966 1
1973 3
1974 2
1976 3
1977 4
1978 4
1979 4
1980 14
1981 4
1982 11
1983 11
1984 22
1985 19
1986 16
1987 24
1988 22
1989 26
1990 41
1991 45
1992 49
1993 67
1994 91
1995 82
1996 115
1997 111
1998 120
1999 137
2000 170
2001 166
2002 255
2003 349
2004 407
2005 514
2006 592
2007 756
2008 877
2009 1007
2010 1178
2011 1468
2012 1694
2013 1971
2014 2318
2015 2689
2016 2833
2017 3273
2018 3608
2019 4220
2020 5269
2021 5821
2022 2731
Text availability
Article attribute
Article type
Publication date

Search Results

40,196 results
Results by year
Filters applied: . Clear all
Page 1
Mitolysosome exocytosis, a mitophagy-independent mitochondrial quality control in flunarizine-induced parkinsonism-like symptoms.
Bao F, Zhou L, Zhou R, Huang Q, Chen J, Zeng S, Wu Y, Yang L, Qian S, Wang M, He X, Liang S, Qi J, Xiang G, Long Q, Guo J, Ying Z, Zhou Y, Zhao Q, Zhang J, Zhang D, Sun W, Gao M, Wu H, Zhao Y, Nie J, Li M, Chen Q, Chen J, Zhang X, Pan G, Zhang H, Li M, Tian M, Liu X. Bao F, et al. Among authors: yang l. Sci Adv. 2022 Apr 15;8(15):eabk2376. doi: 10.1126/sciadv.abk2376. Epub 2022 Apr 13. Sci Adv. 2022. PMID: 35417232 Free PMC article.
FTO mediates LINE1 m6A demethylation and chromatin regulation in mESCs and mouse development.
Wei J, Yu X, Yang L, Liu X, Gao B, Huang B, Dou X, Liu J, Zou Z, Cui XL, Zhang LS, Zhao X, Liu Q, He PC, Sepich-Poore C, Zhong N, Liu W, Li Y, Kou X, Zhao Y, Wu Y, Cheng X, Chen C, An Y, Dong X, Wang H, Shu Q, Hao Z, Duan T, He YY, Li X, Gao S, Gao Y, He C. Wei J, et al. Among authors: yang l. Science. 2022 May 5:eabe9582. doi: 10.1126/science.abe9582. Online ahead of print. Science. 2022. PMID: 35511947
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial.
Lu Z, Wang J, Shu Y, Liu L, Kong L, Yang L, Wang B, Sun G, Ji Y, Cao G, Liu H, Cui T, Li N, Qiu W, Li G, Hou X, Luo H, Xue L, Zhang Y, Yue W, Liu Z, Wang X, Gao S, Pan Y, Galais MP, Zaanan A, Ma Z, Li H, Wang Y, Shen L; ORIENT-15 study group. Lu Z, et al. Among authors: yang l. BMJ. 2022 Apr 19;377:e068714. doi: 10.1136/bmj-2021-068714. BMJ. 2022. PMID: 35440464 Free PMC article. Clinical Trial.
40,196 results
You have reached the last available page of results. Please see the User Guide for more information.